ABCA-1 elevating compounds
US6900219B2 · kind B2 · utility
21Cited by
1References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2003 |
| Grant date | May 31, 2005 |
| Priority date | — |
| Expiry date | Apr 4, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.